Pediatric Hematology-Oncology in Countries with Limited Resources

A Practical Manual
Softcover Nachdruck of the original 1. Auflage 2014
ISBN: 978-1-4939-5351-6
Verlag: Springer

Buch, Englisch, 415 Seiten, Paperback, Format (B × H): 178 mm x 254 mm, Gewicht: 8062 g

Typically, manuals of pediatric hematology-oncology are written by specialists from high-income countries, and usually target an audience with a sub-specialist level of training, often assisted by cutting-edge diagnostic and treatment facilities. However, approximately 80% of new cases of cancer in children appear in mid- and low-income countries. Almost invariably, general practitioners or general pediatricians without special training in oncology will look after children with malignancies who enter the health care system in these countries. The diagnostic facilities are usually limited, as are the treatment options. The survival figures in these conditions are somewhere below 20%, while in high-income countries they are in the range of 80% for many childhood cancers. 

Pediatric Hematology-Oncology in Countries with Limited Resources is the only book of its kind to provide specific guidance applicable to limited resource settings and builds up from the foundation of general practitioner or general pediatrician competence. Written and edited by leaders in the field, this manual educates physicians on the essential components of the discipline, filtered through the experience of specialists from developing countries, with immediate applicability in the specific healthcare environment in these countries.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Rodriguez-Galindo, Carlos

Stefan, Daniela Cristina

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Hämatologie, Transfusionsmedizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Pädiatrie, Neonatologie

Inhaltsverzeichnis

1.  Childhood Cancer in Low-Income and Middle-Income Countries in the Twenty-first Century 2.  Cancer Registries and the Descriptive Epidemiology of Pediatric Cancer in Low and Middle-Income Countries 3. The role of international organizations on collaboration for global pediatric cancer control 4. The role of twinning programs and telemedicine in pediatric oncology in developing countries 5. Pediatric Cancer Units and Optimization of Resources  6. Early Warning Signs of Cancer in Children / Models for Early Diagnosis  7.  Care and Prevention of Infection  8. Nutritional Assessment and Intervention  9.  Oncologic Emergencies in developing countries  10. Essential Medicines and Pharmacy Services in Developing Countries 11. Palliative and Supportive Care  12. Psycho-social Aspects / Parent Support Groups  13. Nursing Care of Children with Cancer in Limited Resource Settings  14. Paediatric Radiotherapy in Developing countries  15. Procedures in Pediatric Oncology: Practical Guidelines 16. Acute Lymphoblastic Leukemia  17. Acute Myeloid Leukemia 18. Hodgkin Lymphoma  19. Non Hodgkin Lymphoma in Low and Middle resource countries  20. Retinoblastoma  21. Soft tissue sarcomas in developing countries 22. BONE TUMORS  23. Neuroblastoma  24. Nephroblastoma in developing countries - a practical approach  25. Paediatric neuro-oncology in countries with limited resources  26. HIV and malignancy in children  27. Hematopoietic stem cell transplant in developing countries- practical guidelines

Über Autor(innen)

Dr. Cristina Stefan is Professor, Senior Consultant, and Head of Hematology and Oncology Service, Department of Pediatrics and Child Health, Univeristy of Stellenbosch and Tygerberg Children's Hospital (South Africa).

Dr. Carlos Rodriguez-Galindo is Associate Medical Director for Clinical Trials at the Dana-Farber Harvard Medical Cancer Center, the Director of the Pediatric Solid Tumor Program, Medical Director of the Pediatric Oncology Clinical Trials, Program Leader for Experimental Therapeutics in the Department of Oncology, Dana-Farber Cancer Institute and Children's Hospital.